{
    "relation": [
        [
            "Company",
            "ALLEGIANT T\u2026",
            "SIMULATIONS\u2026",
            "BOOT BARN H\u2026",
            "AMEDISYS IN\u2026",
            "CAL-MAINE F\u2026"
        ],
        [
            "Symbol",
            "ALGT",
            "SLP",
            "BOOT",
            "AMED",
            "CALM"
        ],
        [
            "Price",
            "219.87",
            "6.66",
            "32.56",
            "44.88",
            "55.11"
        ],
        [
            "%Chg",
            "+3.36%",
            "+3.10%",
            "+3.04%",
            "+2.87%",
            "+1.75%"
        ]
    ],
    "pageTitle": "Wyndham Beats on Both Lines - February 6, 2013 - Zacks.com",
    "title": "",
    "url": "http://www.zacks.com/stock/news/92127/wyndham-beats-on-both-lines",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 0,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990603.54/warc/CC-MAIN-20150728002310-00263-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 839687503,
    "recordOffset": 839666670,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{23777=The company has bought back approximately 2.9 million shares of its common stock worth $151.0 million in the fourth quarter. In 2012, Wyndham repurchased 12.9 million shares for $623 million. Year to date, the company has repurchased 1.1 million shares worth $60 million. Currently about $447.0 million shares remained under its existing share repurchase program., 14851=by Zacks Equity Research \u00a0\u00a0Published on February 06, 2013 |, 63701=Copyright \u00a9 2015 Zacks Investment Research, 21753=Net revenues climbed 9% year over year to $1,094 million in the reported quarter. The quarterly revenues beat the Zacks Consensus Estimate of $1,056 million. The increase reflected growth across Wyndham\u2019s lodging and vacation ownership businesses. In 2012, revenue increased 7% to $4,534 million year over year., 23407=Liquidity Wyndham exited the quarter with cash and cash equivalents of approximately $195.0 million as compared with $230.0 million at the end of previous quarter. As of December 31, 2012, long-term debt was $2.6 billion versus $2.5 billion at September 30, 2012., 21510=In full-year 2012, adjusted earnings per share were $3.23 ahead of the Zacks Consensus Estimate of $3.20 and the year-ago earnings of $2.49. On a reported basis, earnings were $2.75 per share versus $2.51 in the year-ago period., 20473=Wyndham Worldwide Corporation (WYN - Analyst Report) announced fourth quarter 2012 adjusted earnings of 63 cents per share, which surpassed the Zacks Consensus Estimate of 60 cents per share and increased 34% year over year., 63762=At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm., 24375=Management revised its revenue, earnings per share and EBITDA guidance for full-year 2013. The company increased its revenue expectation from $4.90 \u2013 $5.05 billion to $4.925 - $5.100 billion. Wyndham increased the earnings per share guidance range from $3.50 - $3.60 to $3.57 - $3.70 and adjusted EBITDA outlook from $1.125 \u2013 $1.150 billion to $1.140 - $1.165 billion. Our Take}",
    "lastModified": "Tue, 04 Aug 2015 02:41:25 -0500",
    "textBeforeTable": "Income Momentum Value Growth Zacks #1 Rank Top Movers for Aug 4, 2015 Zacks #1 Rank Top Movers Zacks #1 Rank Top Movers for 08/04/15 } } document.getElementById('score_val').className = ''; document.getElementById('score_val').innerHTML = ''; document.getElementById('tab_label').innerHTML = tab_text; { else } document.getElementById('score_val').className = 'scores_val'; document.getElementById('score_val').innerHTML = 'A'; document.getElementById('tab_label').innerHTML = tab_text+ ' Score'; { if(tab_text != 'income') document.getElementById('rank_text').innerHTML = cat_uri; var cat_uri = 'View All Zacks Rank #1 '+tab_text+' Stocks'; var cat_uri = '/stocks/buy-list/'+tab_text; { function footer_text(tab_text)",
    "textAfterTable": "Company Symbol Price %Chg SKYWEST INC\u2026 SKYW 17.10 +3.26% ASSURANT IN\u2026 AIZ 76.33 +2.32% PCM INC PCMI 10.29 +2.18% TRIUMPH BAN\u2026 TBK 14.25 +1.35% BOX SHIPS I\u2026 TEU 0.82 +1.29% Company Symbol Price %Chg IRADIMED CO\u2026 IRMD 25.91 +4.48% AMAG PHARMA\u2026 AMAG 66.20 +3.60% AMEDISYS IN\u2026 AMED 44.88 +2.87% NORDIC AMER\u2026 NAT 15.23 +1.40%",
    "hasKeyColumn": true,
    "keyColumnIndex": 1,
    "headerRowIndex": 0
}